Prestige Consumer Healthcare Inc. - 10-Q Filing
Prestige Consumer Healthcare Inc. reports Q2 2026 results including impact from OTC Wellness Business acquisition and updated debt obligations.
Tickers: $PBH
Read the full article at SEC EDGAR
Part of the story Prestige Consumer Healthcare Inc. - 10-Q Filing (5 articles)